Longevity Health (XAGE) Competitors $2.58 +0.13 (+5.31%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock XAGE vs. POAI, SINT, HSCS, PAVM, SSKN, STRR, LFWD, AMIX, STSS, and PTHLShould you be buying Longevity Health stock or one of its competitors? The main competitors of Longevity Health include Predictive Oncology (POAI), Sintx Technologies (SINT), HeartSciences (HSCS), PAVmed (PAVM), Strata Skin Sciences (SSKN), Star Equity (STRR), Lifeward (LFWD), Autonomix Medical (AMIX), Sharps Technology (STSS), and Pheton (PTHL). These companies are all part of the "medical equipment" industry. Longevity Health vs. Its Competitors Predictive Oncology Sintx Technologies HeartSciences PAVmed Strata Skin Sciences Star Equity Lifeward Autonomix Medical Sharps Technology Pheton Predictive Oncology (NASDAQ:POAI) and Longevity Health (NASDAQ:XAGE) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability. Which has more volatility and risk, POAI or XAGE? Predictive Oncology has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Comparatively, Longevity Health has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Does the media prefer POAI or XAGE? In the previous week, Predictive Oncology had 3 more articles in the media than Longevity Health. MarketBeat recorded 6 mentions for Predictive Oncology and 3 mentions for Longevity Health. Longevity Health's average media sentiment score of 0.46 beat Predictive Oncology's score of -0.52 indicating that Longevity Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Predictive Oncology 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Longevity Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend POAI or XAGE? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Longevity Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is POAI or XAGE more profitable? Predictive Oncology has a net margin of -587.31% compared to Longevity Health's net margin of -682.67%. Longevity Health's return on equity of 0.00% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Predictive Oncology-587.31% -722.01% -167.23% Longevity Health -682.67%N/A -297.15% Which has preferable valuation & earnings, POAI or XAGE? Longevity Health has lower revenue, but higher earnings than Predictive Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPredictive Oncology$1.66M5.89-$12.66M-$3.05-0.30Longevity Health$1.05M2.46-$10.37MN/AN/A Do institutionals and insiders hold more shares of POAI or XAGE? 9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 24.2% of Longevity Health shares are held by institutional investors. 3.4% of Predictive Oncology shares are held by insiders. Comparatively, 29.0% of Longevity Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryPredictive Oncology beats Longevity Health on 7 of the 12 factors compared between the two stocks. Get Longevity Health News Delivered to You Automatically Sign up to receive the latest news and ratings for XAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XAGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XAGE vs. The Competition Export to ExcelMetricLongevity HealthSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$2.59M$166.71M$2.55B$9.65BDividend YieldN/AN/A2.55%4.09%P/E RatioN/A2.4622.0925.12Price / Sales2.465.1977.87157.42Price / CashN/A4.1523.4628.45Price / Book-0.381.6335.465.94Net Income-$10.37M-$66.04M$31.01M$265.56M7 Day Performance16.74%-0.50%0.10%0.95%1 Month Performance-28.93%-8.02%0.91%2.47%1 Year PerformanceN/A154.44%28.21%20.24% Longevity Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XAGELongevity HealthN/A$2.58+5.3%N/AN/A$2.59M$1.05M0.0014News CoverageEarnings ReportGap DownPOAIPredictive Oncology0.3216 of 5 stars$0.86-1.6%$3.00+250.4%-2.5%$8.89M$1.73M-0.2830Earnings ReportSINTSintx Technologies2.4396 of 5 stars$3.04-0.3%$28.00+821.1%-28.5%$8.40M$2.89M-0.0640Earnings ReportShort Interest ↓Gap DownHSCSHeartSciences3.3473 of 5 stars$3.38-3.4%$13.00+284.6%+4.7%$7.97MN/A-0.3610Positive NewsPAVMPAVmed4.6004 of 5 stars$0.45-1.4%$19.00+4,124.1%-36.5%$7.80M$1.99M0.3990SSKNStrata Skin Sciences2.5351 of 5 stars$1.84+1.7%$6.00+226.1%-29.5%$7.55M$33.56M-0.65120Earnings ReportSTRRStar Equity2.5326 of 5 stars$2.13-2.7%$5.00+134.7%-52.7%$7.08M$53.36M-2.09460Earnings ReportLFWDLifeward2.6987 of 5 stars$0.63+3.4%$9.00+1,322.7%-82.8%$6.74M$25.41M-0.2060Earnings ReportAMIXAutonomix Medical2.7601 of 5 stars$1.13flat$16.50+1,360.2%-91.0%$5.81MN/A-0.201News CoverageEarnings ReportShort Interest ↑STSSSharps Technology2.0893 of 5 stars$4.97-2.9%N/AN/A$5.24MN/A0.003News CoveragePositive NewsEarnings ReportShort Interest ↓Gap DownPTHLPhetonN/A$0.63-5.2%N/AN/A$4.39M$450K0.0011News CoveragePositive NewsGap Down Related Companies and Tools Related Companies Predictive Oncology Alternatives Sintx Technologies Alternatives HeartSciences Alternatives PAVmed Alternatives Strata Skin Sciences Alternatives Star Equity Alternatives Lifeward Alternatives Autonomix Medical Alternatives Sharps Technology Alternatives Pheton Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XAGE) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longevity Health Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longevity Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access